About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Philadelphia | 153 Studies

Clinical Trials SchizophreniaPhiladelphia

Schizophrenia Clinical Trials in Philadelphia

Find 153 clinical trials for schizophrenia near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 153 trials

Active not recruitingAMP SCZ® Observational Study: PREDICT-DPACCThe Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) is a large international collaboration to develop algorithms using a set of clinical and cognitive assessments…NCT05905003·Irvine, California and 41 others

Schizophrenia Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedPharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With SchizophreniaThis is a single ascending dose phase 1 study to evaluate the pharmacokinetics (PK), safety, and tolerability of a single intramuscular (IM) injection of quarterly Risperidone…NCT06276361·Amman

CompletedA Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of SchizophreniaThis randomized, double-blind, placebo- and active-controlled, parallel group study will evaluate the safety and efficacy of RO4917838 (bitopertin) in patients with acute…NCT01234779·Little Rock, Arkansas and 45 others

CompletedStudy of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With SchizophreniaThe purpose of this study is to demonstrate that a paliperidone palmitate 3 month formulation (PP3M) is as effective as the paliperidone palmitate 1 month formulation (PP1M) in…NCT01515423·Little Rock, Arkansas and 173 others

CompletedRelapse Prevention Study of Pimavanserin in Dementia-related PsychosisThe purpose of this study is to evaluate the efficacy of pimavanserin compared to placebo in preventing relapse of psychotic symptoms in subjects with dementia-related psychosis…NCT03325556·Costa Mesa, California and 82 others

CompletedA Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With SchizophreniaThe study will determine the efficacy of ALKS 9072 (also known as aripiprazole lauroxil or ALKS 9070) for the treatment of schizophrenia in subjects experiencing an acute…NCT01469039·Little Rock, Arkansas and 83 others

CompletedMelatonin Effects on Sleep and Circadian Rhythm in Youth and Young Adults With At-risk SymptomsRandomized control trial assessing supplemental melatonin for youth with at-risk or psychotic symptoms.NCT03826563·Philadelphia, Pennsylvania

CompletedA Comparator Study of LY2140023 Versus Placebo in Schizophrenia PatientsAn inpatient/outpatient study to see if LY2140023 is better than placebo in acutely ill patients with schizophrenia.NCT01086748·Escondido, California and 27 others

CompletedSystematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)A long-term study of current treatments for bipolar disorder, including medications and psychosocial therapies.NCT00012558·Stanford, California and 10 others

CompletedSwitch Study of Existing Atypical Antipsychotics to BifeprunoxThe study will evaluate the safety and tolerability of switching subjects with schizophrenia or schizoaffective disorder from their existing antipsychotic medication to Bifeprunox.NCT00347425·Birmingham, Alabama and 121 others

TerminatedLong-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of SchizophreniaThe primary purpose of this study is to determine if the long-term use of SPD489 (40, 80, 100, 120, 140, and 160mg) administered as a daily morning is safe and tolerable.NCT01760993·Oklahoma City, Oklahoma and 1 other

CompletedPEARL Schizophrenia MaintenanceLurasidone HCI is a compound that is FDA-approved for the treatment of schizophrenia.NCT01435928·Springdale, Arizona and 74 others

CompletedA Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or SchizophreniformThe purpose of the study is to compare effectiveness of paliperidone palmitate (PP: paliperidone palmitate once-monthly and 3-month injections) versus oral antipsychotic (OAP…NCT02431702·Little Rock, Arkansas and 37 others

CompletedOlanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With SchizophreniaTo compare the health outcome of patients with schizophrenia, who are at risk for relapse, when treated with a long acting injection form of olanzapine versus treatment with oral…NCT00320489·Escondido, California and 48 others

CompletedFeasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical NetworkThis study will test whether a cognitive remediation program to treat people with schizophrenia can be successfully implemented in a network of research clinics.NCT00930150·New Haven, Connecticut and 8 others

CompletedIntramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaTo evaluate the overall effectiveness of aripiprazole intramuscular (IM) depot as maintenance treatment in patients with schizophrenia.NCT00731549·Chandler, Arizona and 213 others

CompletedQuetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I DisorderThe purpose of this study is to demonstrate the efficacy and safety of quetiapine fumarate (SEROQUEL) in the treatment of adolescent patients with schizophrenia and bipolar I…NCT00227305·Dothan, Alabama and 47 others

CompletedA Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)This Phase 2, double-blind, placebo-controlled, randomized study is to assess the safety, efficacy, and pharmacokinetics (PK) of miricorilant (CORT118335) in obese patients with…NCT04524403·Bentonville, Arkansas and 39 others

CompletedA Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I DisorderThe purpose of this study is to evaluate the effectiveness and safety of flexible-doses paliperidone ER (3 to 12 mg as needed) compared with placebo over 3 weeks in patients with…NCT00309699·Cerritos, California and 46 others

CompletedCSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar IllnessThe purpose of this study is to detect genetic associations for the development of schizophrenia (SZ) and bipolar illness (BP) by comparing Veterans with these diseases to…NCT01149551·Birmingham, Alabama and 24 others

PreviousPage 2 of 8Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia